Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 22, Issue 14, Pages 3829
Publisher
Baishideng Publishing Group Inc.
Online
2016-04-07
DOI
10.3748/wjg.v22.i14.3829
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glypican-3 as a specific biomarker for hepatocellular carcinoma
- (2015) Min Yao et al. Hepatobiliary & Pancreatic Diseases International
- Alterations of Wnt/β-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis C virus
- (2015) Karol Rogacki et al. POLISH JOURNAL OF PATHOLOGY
- Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer
- (2014) Myung Ah Lee et al. BMC CANCER
- The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets
- (2014) Marc Ringelhan et al. JOURNAL OF PATHOLOGY
- �-Catenin(CTNNB1)Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma
- (2014) Li-Chun Lu et al. ONCOLOGY
- Cytoplasmic and/or Nuclear Expression of β-Catenin Correlate with Poor Prognosis and Unfavorable Clinicopathological Factors in Hepatocellular Carcinoma: A Meta-Analysis
- (2014) Jiang Chen et al. PLoS One
- Molecular Profiling of Liver Tumors: Classification and Clinical Translation for Decision Making
- (2014) Roser Pinyol et al. SEMINARS IN LIVER DISEASE
- Regulation of Wnt/β-catenin signaling by posttranslational modifications
- (2014) Chenxi Gao et al. Cell and Bioscience
- Wnt/β-catenin signaling enhances hypoxia-induced epithelial–mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling
- (2013) Qi Zhang et al. CARCINOGENESIS
- Wnt signaling and hepatocarcinogenesis: Molecular targets for the development of innovative anticancer drugs
- (2013) Floriane Pez et al. JOURNAL OF HEPATOLOGY
- Sorafenib sensitizes hepatocellular carcinoma cell to cisplatin via suppression of Wnt/β-catenin signaling
- (2013) Yongpeng Wei et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma
- (2013) Navjot Kaur et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Wnt Pathway Activity in Breast Cancer Sub-Types and Stem-Like Cells
- (2013) Rebecca Lamb et al. PLoS One
- Molecular Mechanisms of HBV-Associated Hepatocarcinogenesis
- (2013) Francesca Guerrieri et al. SEMINARS IN LIVER DISEASE
- Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring
- (2013) Li Wang et al. TUMOR BIOLOGY
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
- (2012) Mary Maluccio et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review)
- (2012) KAI SONG et al. ONCOLOGY REPORTS
- Krüppel-Like Factor 8 Is a New Wnt/Beta-Catenin Signaling Target Gene and Regulator in Hepatocellular Carcinoma
- (2012) Tian Yang et al. PLoS One
- Wnt Proteins
- (2012) K. Willert et al. Cold Spring Harbor Perspectives in Biology
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- WNT-3A modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways
- (2011) Giovanna Nalesso et al. JOURNAL OF CELL BIOLOGY
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- The oncogenic effect of sulfatase 2 in human hepatocellular carcinoma is mediated in part by glypican 3-dependent Wnt activation
- (2010) Jin-Ping Lai et al. HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now